Hippocratic AI, a startup aiming to revolutionize healthcare through generative artificial intelligence (AI), recently announced an extension of its Series A funding round, bringing the total investment to $137 million. The company welcomed new investors, including NVentures—the venture capital arm of NVIDIA—Greycroft, and Lee Shapiro of 7Wire Ventures. This marks one of NVentures' first non-biotech healthcare investments, signaling a significant shift in venture capital interest towards AI-driven healthcare solutions.
While the infusion of capital underscores the growing confidence in AI's potential to transform healthcare, it has also ignited a heated debate. Critics question whether pouring such substantial funds into AI startups like Hippocratic AI is the most effective way to a
The Controversy Surrounding Hippocratic AI’s Latest Funding
- By 재은
- Published on
Hippocratic AI's recent $137 million funding sparks controversy over whether investing heavily in AI startups is the best use of capital amid pressing healthcare needs.
